The ancient Greeks depicted an ideal form and physique known as the “Grecian ideal” featuring chiseled, seemingly perfect muscles that we see in so many of the sculptures of the sixth century. Achieving this ideal had the benefit of intimidating enemies and producing a dashing appearance.
Now science is revealing that muscle health can also be a predictor of patient outcomes in cancer treatment. In fact, low muscle mass (also termed sarcopenia) and poor muscle quality (myosteatosis) are prevalent and independent predictors of poor patient outcomes in cancer.
Read this white paper to learn why muscle mass should be assessed, or at least screened for, in all oncologic patients regardless of weight status, cancer type or stage of disease.
